Frost recognised Slendesta’s clinically-backed ability to increase, “the body’s release of a natural hunger-suppressing substance known as cholecystokinin”.
Slendesta’s clean-label profile boosted its allure, Frost said, along with Kemin’s B2B and B2c education campaign.





